Cellsight Technologies, Inc

Gel Company, based in San Francisco, CA, specializes in providing high-quality genomics and proteomics analysis tools, along with a wide range of laboratory supplies and accessories. Their product offerings include electrophoresis imaging systems, PCR consumables, microarrays, and various reagents, catering to the needs of research facilities and laboratories. Committed to innovation and customer satisfaction, Gel Company ensures a friendly and efficient service that pairs competitive pricing with an extensive catalog of reliable products. They also offer valuable resources such as user manuals, service requests, and instructional videos to support their customers effectively. Generated from the website

MandalMed, Inc. is a San Francisco-based company specializing in research and development in the field of medicine. With a focus on intellectual property, they are dedicated to advancing innovative solutions for healthcare. Driven by a team of experts, MandalMed is committed to pushing the boundaries of medical technology and improving patient outcomes. Their cutting-edge research and development efforts position them at the forefront of the industry, making them a key player in the future of healthcare.Generated from the website

Shasqi, Inc is a pioneering biotech company based in San Francisco, CA, that is revolutionizing cancer treatment through their innovative Click Activated Protodrugs Against Cancer (CAPAC) approach. Using Nobel Prize-winning click chemistry technology, Shasqi activates cancer therapies specifically at the tumor site, offering a targeted and effective solution for patients. By separating tumor targeting from the payload and relying on chemistry rather than biology for activation, Shasqi's CAPAC approach provides unprecedented flexibility, potentially leading to enhanced therapeutic activity and reduced toxicity. With their validated clinical success and commitment to advancing novel therapies, Shasqi is at the forefront of transforming cancer treatment and offering hope to patients with limited effective treatment options.Generated from the website